id paper:paper_21624011_v2_n4_p_Compagno
record_format dspace
spelling paper:paper_21624011_v2_n4_p_Compagno2023-06-08T16:34:30Z Delineating the "galectin signature" of the tumor microenvironment Angiogenesis Galectins Gene signature Metastasis Prostate cancer angiogenesis inhibitor ecalectin galectin galectin 1 galectin 12 galectin 3 galectin 4 galectin 8 messenger RNA short hairpin RNA unclassified drug advanced cancer antiangiogenic therapy article cancer cell culture cancer growth cancer prognosis cancer staging cancer therapy castration resistant prostate cancer cell invasion cell migration cellular immunity down regulation human hypoxia Kaposi sarcoma molecular mechanics prostate cancer prostatectomy protein carbohydrate interaction protein expression protein function protein structure protein synthesis inhibition protein targeting structure analysis tumor microenvironment tumor vascularization upregulation Galectins, a family of glycan-binding proteins, can control tumor progression by promoting transformation, angiogenesis and immune escape. We identified a dynamically regulated 'galectin signature', which delineates the progression of prostate cancer, highlighting galectin-1 as an attractive target for anti-angiogenic therapy in advanced stages of the disease. © 2013 Landes Bioscience. 2013 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_21624011_v2_n4_p_Compagno http://hdl.handle.net/20.500.12110/paper_21624011_v2_n4_p_Compagno
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Angiogenesis
Galectins
Gene signature
Metastasis
Prostate cancer
angiogenesis inhibitor
ecalectin
galectin
galectin 1
galectin 12
galectin 3
galectin 4
galectin 8
messenger RNA
short hairpin RNA
unclassified drug
advanced cancer
antiangiogenic therapy
article
cancer cell culture
cancer growth
cancer prognosis
cancer staging
cancer therapy
castration resistant prostate cancer
cell invasion
cell migration
cellular immunity
down regulation
human
hypoxia
Kaposi sarcoma
molecular mechanics
prostate cancer
prostatectomy
protein carbohydrate interaction
protein expression
protein function
protein structure
protein synthesis inhibition
protein targeting
structure analysis
tumor microenvironment
tumor vascularization
upregulation
spellingShingle Angiogenesis
Galectins
Gene signature
Metastasis
Prostate cancer
angiogenesis inhibitor
ecalectin
galectin
galectin 1
galectin 12
galectin 3
galectin 4
galectin 8
messenger RNA
short hairpin RNA
unclassified drug
advanced cancer
antiangiogenic therapy
article
cancer cell culture
cancer growth
cancer prognosis
cancer staging
cancer therapy
castration resistant prostate cancer
cell invasion
cell migration
cellular immunity
down regulation
human
hypoxia
Kaposi sarcoma
molecular mechanics
prostate cancer
prostatectomy
protein carbohydrate interaction
protein expression
protein function
protein structure
protein synthesis inhibition
protein targeting
structure analysis
tumor microenvironment
tumor vascularization
upregulation
Delineating the "galectin signature" of the tumor microenvironment
topic_facet Angiogenesis
Galectins
Gene signature
Metastasis
Prostate cancer
angiogenesis inhibitor
ecalectin
galectin
galectin 1
galectin 12
galectin 3
galectin 4
galectin 8
messenger RNA
short hairpin RNA
unclassified drug
advanced cancer
antiangiogenic therapy
article
cancer cell culture
cancer growth
cancer prognosis
cancer staging
cancer therapy
castration resistant prostate cancer
cell invasion
cell migration
cellular immunity
down regulation
human
hypoxia
Kaposi sarcoma
molecular mechanics
prostate cancer
prostatectomy
protein carbohydrate interaction
protein expression
protein function
protein structure
protein synthesis inhibition
protein targeting
structure analysis
tumor microenvironment
tumor vascularization
upregulation
description Galectins, a family of glycan-binding proteins, can control tumor progression by promoting transformation, angiogenesis and immune escape. We identified a dynamically regulated 'galectin signature', which delineates the progression of prostate cancer, highlighting galectin-1 as an attractive target for anti-angiogenic therapy in advanced stages of the disease. © 2013 Landes Bioscience.
title Delineating the "galectin signature" of the tumor microenvironment
title_short Delineating the "galectin signature" of the tumor microenvironment
title_full Delineating the "galectin signature" of the tumor microenvironment
title_fullStr Delineating the "galectin signature" of the tumor microenvironment
title_full_unstemmed Delineating the "galectin signature" of the tumor microenvironment
title_sort delineating the "galectin signature" of the tumor microenvironment
publishDate 2013
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_21624011_v2_n4_p_Compagno
http://hdl.handle.net/20.500.12110/paper_21624011_v2_n4_p_Compagno
_version_ 1768544570936655872